Hemodynamic support: Science and evaluation of the assisted circulation with percutaneous assist devices

Interventional Cardiology Clinics

Volumn 2, Issue 3, 2013, Pages 407-416

  Burkhoff, Daniel ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cardiogenic shock; Circulatory support; Contractility; EDPVR; ESPVR; Pressure volume area; Pressure volume relationships

Indexed keywords

AORTA FLOW; ARTERY RESISTANCE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BLOOD FLOW; COUNTERPULSATION; COUNTERPULSATION DEVICE; EXTRACORPOREAL MEMBRANE OXYGENATION DEVICE; EXTRACORPOREAL OXYGENATION; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PRELOAD; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PRESSURE; HUMAN; INTRAAORTIC BALLOON PUMP; INTRACORPOREAL TRANSAORTIC VALVE CIRCULATORY SUPPORT; LUNG CAPILLARY PRESSURE; MEAN ARTERIAL PRESSURE; MEDICAL DEVICE; METABOLIC PARAMETERS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; VENTRICULAR ASSIST DEVICE;

EID: 84880041962     PISSN: 22117458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccl.2013.03.001     Document Type: Review

References (35)

1. Cuffe M.S., Califf R.M., Adams K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541-1547.
2. Abraham W.T., Adams K.F., Fonarow G.C., et al. In-hospitalmortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). JAm Coll Cardiol 2005, 46:57-64.
3. Dunser M.W., Hasibeder W.R. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. JIntensive Care Med 2009, 24:293-316.
4. Goldspink D.F., Burniston J.G., Ellison G.M., et al. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat invivo: the same or separate death pathways?. Exp Physiol 2004, 89:407-416.
5. Culling W., Penny W.J., Cunliffe G., et al. Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion. JMol Cell Cardiol 1987, 19:251-258.
6. Burkhoff D., Mirsky I., Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005, 289:H501-H512.
7. Burkhoff D., Naidu S.S. The science behind percutaneous hemodynamic support: a review and comparison of support strategies. Catheter Cardiovasc Interv 2012, 80:816-829.
8. Burkhoff D., Tyberg J.V. Why does pulmonary venous pressure rise following the onset of left ventricular dysfunction: a theoretical analysis. Am J Physiol 1993, 265(HCP 34):H1819-H1828.
9. Sunagawa K., Maughan W.L., Burkhoff D., et al. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983, 245(HCP 14):H773-H780.
10. Fincke R., Hochman J.S., Lowe A.M., et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. JAm Coll Cardiol 2004, 44:340-348.
11. Torgersen C., Schmittinger C.A., Wagner S., et al. Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study. Crit Care 2009, 13:R157.
12. Mendoza D.D., Cooper H.A., Panza J.A. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 2007, 153:366-370.
13. Chatterjee K. Coronary hemodynamics in heart failure and effects of therapeutic interventions. JCard Fail 2009, 15:116-123.
14. Suga H. Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol 1979, 236:H498-H505.
15. Takaoka H., Takeuchi M., Odake M., et al. Comparison of hemodynamic determinants for myocardial oxygen consumption under different contractile states in human ventricle. Circulation 1993, 87:59-69.
16. Schipke J.D., Burkhoff D., Kass D.A., et al. Hemodynamic dependence of myocardial oxygen consumption indices. Am J Physiol 1990, 258(HCP 27):H1281-H1291.
17. Krams R., Sipkema P., Zegers J., et al. Contractility is the main determinant of coronary systolic flow impediment. Am J Physiol 1989, 257:H1936-H1944.
18. Krams R., Sipkema P., Westerhof N. Varying elastance concept may explain coronary systolic flow impediment. Am J Physiol 1989, 257:H1471-H1479.
19. Petersen J.W., Felker G.M. Inotropes in the management of acute heart failure. Crit Care Med 2008, 36:S106-S111.
20. El Mokhtari N.E., Arlt A., Meissner A., et al. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine. Eur J Med Res 2008, 13:459-463.
21. de Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. NEngl J Med 2010, 362:779-789.
22. Samuels L.E., Kaufman M.S., Thomas M.P., et al. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. JCard Surg 1999, 14:288-293.
23. Sauren L.D., Accord R.E., Hamzeh K., et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs 2007, 31:839-842.
24. Reesink K.D., Dekker A.L., Van Ommen V., et al. Miniature intracardiac assist device provides more effective cardiac unloading and circulatory support during severe left heart failure than intraaortic balloon pumping. Chest 2004, 126:896-902.
25. Seyfarth M., Sibbing D., Bauer I., et al. Arandomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. JAm Coll Cardiol 2008, 52:1584-1588.
26. Kawashima D., Gojo S., Nishimura T., et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 2011, 57:169-176.
27. Thiele H., Zeymer U., Neumann F.J., et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. NEngl J Med 2012, 367:1287-1296.
28. Burkhoff D., O'Neill W., Brunckhorst C., et al. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv 2006, 68:211-217.
29. Burkhoff D., Cohen H., Brunckhorst C., et al. Arandomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006, 152:469.e1-469.e8.
30. Morley D., Litwak K., Ferber P., et al. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with invivo data. JThorac Cardiovasc Surg 2007, 133:21-28.
31. Sweeney M.S. The Hemopump in 1997: a clinical, political, and marketing evolution. Ann Thorac Surg 1999, 68:761-763.
32. Raess D.H., Weber D.M. Impella 2.5. JCardiovasc Transl Res 2009, 2:168-172.
33. Remmelink M., Sjauw K.D., Henriques J.P., et al. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 2007, 70:532-537.
34. O'Neill W.W., Kleiman N.S., Moses J., et al. Aprospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012, 126:1717-1727.
35. Thiele H., Lauer B., Hambrecht R., et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001, 104:2917-2922.